Transforming growth factor β latency: A mechanism of cytokine storage and signalling regulation in liver homeostasis and disease.

Transforming growth factor β latency: A mechanism of cytokine storage and signalling regulation in liver homeostasis and disease.
复制标题

转化生长因子β潜伏期:肝稳态和疾病中细胞因子储存和信号调节的机制。

DOI:
10.1016/j.jhepr.2021.100397
复制
发表时间:
2022-03
期刊:
JHEP reports : innovation in hepatology
影响因子:
--
通讯作者:
Dooley S
Dooley S
中科院分区:
其他
文献类型:
--
作者:
Li Y;Fan W;Link F;Wang S;Dooley S

文献摘要

参考文献

被引文献

相似文献

转化生长因子-β(Transforming growth factor-β,TGF-β)是肝脏中的一种有效效应物,其参与了肝损伤后启动的多种过程。TGF-β以高度依赖于环境的方式影响实质、非实质和炎症细胞。其生物利用度对于快速响应各种损伤至关重要。在肝脏中-并且可能在其他器官中-这是通过在细胞外基质中沉积大部分TGF-β作为称为潜伏TGF-β(L-TGF-β)的失活前体形式而实现的。几种基质体蛋白参与基质沉积、潜在复合物稳定和L-TGF-β的活化。细胞外基质蛋白1(ECM 1)最近被鉴定为维持健康肝脏中沉积的L-TGF-β的潜伏期的关键因素。事实上,其消耗引起自发的TGF-β信号传导激活,对肝脏结构和功能具有有害影响。本文综述了目前对细胞内L-TGF-β复合物形成、分泌、基质沉积和活化的认识,并描述了所涉及的蛋白质和过程。此外,我们强调了在肝纤维化和肝癌中减弱L-TGF-β活化的治疗潜力。
Transforming growth factor-β (TGF-β) is a potent effector in the liver, which is involved in a plethora of processes initiated upon liver injury. TGF-β affects parenchymal, non-parenchymal, and inflammatory cells in a highly context-dependent manner. Its bioavailability is critical for a fast response to various insults. In the liver – and probably in other organs – this is made possible by the deposition of a large portion of TGF-β in the extracellular matrix as an inactivated precursor form termed latent TGF-β (L-TGF-β). Several matrisomal proteins participate in matrix deposition, latent complex stabilisation, and activation of L-TGF-β. Extracellular matrix protein 1 (ECM1) was recently identified as a critical factor in maintaining the latency of deposited L-TGF-β in the healthy liver. Indeed, its depletion causes spontaneous TGF-β signalling activation with deleterious effects on liver architecture and function. This review article presents the current knowledge on intracellular L-TGF-β complex formation, secretion, matrix deposition, and activation and describes the proteins and processes involved. Further, we emphasise the therapeutic potential of toning down L-TGF-β activation in liver fibrosis and liver cancer.
DOI: 10.1006/abio.1994.1042
发表时间: 1994-02-01
影响因子: 2.9
作者:
ABE, M;HARPEL, JG;RIFKIN, DB
通讯作者: RIFKIN, DB
DOI: 10.1038/mi.2013.53
发表时间: 2014-03
期刊: Mucosal immunology
影响因子: 8
作者:
通讯作者: --
DOI: 10.1083/jcb.201308031
发表时间: 2014-05-12
期刊: The Journal of cell biology
影响因子: --
作者:
Alcaraz LB;Exposito JY;Chuvin N;Pommier RM;Cluzel C;Martel S;Sentis S;Bartholin L;Lethias C;Valcourt U
通讯作者: Valcourt U
DOI: 10.1371/journal.ppat.1001136
发表时间: 2010-10-07
期刊: PLoS pathogens
影响因子: 6.7
作者:
Carlson CM;Turpin EA;Moser LA;O'Brien KB;Cline TD;Jones JC;Tumpey TM;Katz JM;Kelley LA;Gauldie J;Schultz-Cherry S
通讯作者: Schultz-Cherry S
DOI: 10.1210/me.10.9.1077
发表时间: 1996-09-01
影响因子: --
作者:
BarcellosHoff, MH;Dix, TA
通讯作者: Dix, TA